Skip to main content

02 · Clinical Findings

Incretin Drug May Improve Menstrual Regularity

MedPage Today1 min read

In a prospective cohort of 1,945 participants, combined GLP-1/GIP drug users had a 2.5-day reduction in cycle length.

Image from the article by MedPage Today: Incretin Drug May Improve Menstrual Regularity
Image: MedPage Today

A combined GLP-1/GIP drug was linked to more regular menstrual cycles in a prospective cohort analysis.

Among 1,945 participants, users of the combination drug saw cycle length drop by 2.5 days, versus 0.4 days with GLP-1 drugs and 0.8 days among never-users.

Cycle variability was also lower, especially among participants with PMOS, formerly called PCOS. The findings show an association; further research is needed.

DisclaimerEducational news and research awareness content. Not medical advice.Read full disclaimer ▾

This page shares third-party news coverage, official research listings, and public clinical updates for educational awareness only. Catalyst does not present this information as medical advice, treatment guidance, or a claim of safety, efficacy, or approval.

Related context

How this story connects across the peptide landscape.

Continue reading · Clinical FindingsPeptide News / Clinical FindingsTriple-Target Incretin Drug Kills Knee Osteoarthritis Pain in ObesityMedPage Today · Nov 8, 2026 · scroll to read